首页 > 最新文献

Korean journal of clinical oncology最新文献

英文 中文
Rare case of postoperative mediastinitis following thyroidectomy. 甲状腺切除术后纵隔炎罕见病例。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21009
In Soo Cho, Moo Hyun Lee, Jihyoung Cho

Descending necrotizing mediastinitis (DNM) is a life-threatening complication secondary to oropharyngeal abscesses, cervical esophageal perforation, or neck infections spreading along the fascial planes into the mediastinum. Post-thyroidectomy surgical site infection is a highly unusual complication that is typically localized around the incision, but may be propagated into the mediastinum, causing DNM. We encountered a case of this rare complication after thyroidectomy. The patient was a 33-year-old woman who was admitted to our center for left hemithyroidectomy. The surgery was performed without any intraoperative events. However, she later developed fever, hypotension, and tachycardia. Imaging revealed deep neck emphysema and focal pneumomediastinum with infiltration in the anterior neck and mediastinum with abscess formation. Additional imaging at 7 days postoperatively revealed reduced fluid collection deep in the neck with minimal changes in fluid collection in the mediastinum. Esophageal perforation was excluded via an esophagogram, which lead to the conclusion that the infection may have been caused by open thyroidectomy. The patient was treated with prompt medical and surgical intervention. After treatment, she was discharged from the hospital with no further complications. We present our case report as well as a literature review of the diagnosis and treatment of this disease.

下行坏死性纵隔炎(DNM)是一种危及生命的并发症,继发于口咽脓肿、颈部食管穿孔或沿筋膜平面扩散到纵隔的颈部感染。甲状腺切除术后手术部位感染是一种非常罕见的并发症,通常局限于切口周围,但也可能扩散到纵隔,导致DNM。我们在甲状腺切除术后遇到一例这种罕见的并发症。患者是一名33岁的女性,因左侧甲状腺切除术而入院。手术无任何术中事件发生。然而,她后来出现发烧、低血压和心动过速。影像显示深颈肺气肿及局灶性纵隔气肿伴前颈浸润及纵隔脓肿形成。术后7天的附加成像显示颈部深部积液减少,纵隔积液变化很小。经食管造影排除食管穿孔,推测感染可能是开放性甲状腺切除术所致。患者得到了及时的医疗和手术治疗。经治疗后,她出院,无其他并发症。我们提出我们的病例报告,以及诊断和治疗这种疾病的文献综述。
{"title":"Rare case of postoperative mediastinitis following thyroidectomy.","authors":"In Soo Cho,&nbsp;Moo Hyun Lee,&nbsp;Jihyoung Cho","doi":"10.14216/kjco.21009","DOIUrl":"https://doi.org/10.14216/kjco.21009","url":null,"abstract":"<p><p>Descending necrotizing mediastinitis (DNM) is a life-threatening complication secondary to oropharyngeal abscesses, cervical esophageal perforation, or neck infections spreading along the fascial planes into the mediastinum. Post-thyroidectomy surgical site infection is a highly unusual complication that is typically localized around the incision, but may be propagated into the mediastinum, causing DNM. We encountered a case of this rare complication after thyroidectomy. The patient was a 33-year-old woman who was admitted to our center for left hemithyroidectomy. The surgery was performed without any intraoperative events. However, she later developed fever, hypotension, and tachycardia. Imaging revealed deep neck emphysema and focal pneumomediastinum with infiltration in the anterior neck and mediastinum with abscess formation. Additional imaging at 7 days postoperatively revealed reduced fluid collection deep in the neck with minimal changes in fluid collection in the mediastinum. Esophageal perforation was excluded via an esophagogram, which lead to the conclusion that the infection may have been caused by open thyroidectomy. The patient was treated with prompt medical and surgical intervention. After treatment, she was discharged from the hospital with no further complications. We present our case report as well as a literature review of the diagnosis and treatment of this disease.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"52-55"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/62/kjco-17-1-52.PMC9942740.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9215081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of the clinical characteristics and outcomes of HR-positive HER2-negative breast cancer patients over and under 65 years old. 65岁以上和65岁以下hr2阳性乳腺癌患者临床特征及转归的比较研究
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21001
Chang Shin Jung, Youn Joo Jung, Dong Il Kim, Seungju Lee, Seok Kyung Kang, Su Bong Nam, Hyun Yul Kim

Purpose: The purpose of this study was to compare the clinical characteristics and outcomes of hormone receptor-positive (HR+) human epidermal growth factor 2-negative (HER2-) breast cancer among elderly patients (over 65 years old) and younger patients.

Methods: This was a retrospective cohort study of 328 patients who were treated for breast cancer at Pusan National University Yangsan Hospital between January 2009 and December 2014. Tumor characteristics, surgical methods, and survival outcomes were compared between the two age groups (<65 and ≥65 years old). Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) were also constructed according to the age groups.

Results: Among the 328 patients with HR+ HER2- breast cancer, 184 (56.1%) were <65 years old and 144 (43.9%) were ≥65 years old. Breast cancer stages were similar between the two age groups, but the older patients were treated less often with chemotherapy (81% vs. 66%, P=0.002). During the follow-up period, 17 deaths and 36 cases of recurrence or metastasis were reported. There was no difference in DFS between the two groups (P=0.840); however, the OS of the older age group was significantly lower than that of the younger age group (P=0.015).

Conclusion: This study suggested that HR+ HER2- breast cancer patients belonging to the two age groups had no significant difference in DFS. However, older age is an independent factor affecting OS rate. Therefore, even if patients are old, but their physical condition is satisfactory, standard and active treatment may be necessary, similar to that given to younger patients.

目的:本研究的目的是比较老年患者(65岁以上)和年轻患者的激素受体阳性(HR+)人表皮生长因子2阴性(HER2-)乳腺癌的临床特征和预后。方法:对2009年1月至2014年12月在釜山国立大学梁山医院接受乳腺癌治疗的328例患者进行回顾性队列研究。结果:328例HR+ HER2-乳腺癌患者中,184例(56.1%)为:结论:本研究提示两组HR+ HER2-乳腺癌患者的DFS无显著差异。然而,年龄是影响OS率的独立因素。因此,即使患者年事已高,但其身体状况令人满意,也可能需要标准和积极的治疗,类似于对年轻患者的治疗。
{"title":"A comparative study of the clinical characteristics and outcomes of HR-positive HER2-negative breast cancer patients over and under 65 years old.","authors":"Chang Shin Jung,&nbsp;Youn Joo Jung,&nbsp;Dong Il Kim,&nbsp;Seungju Lee,&nbsp;Seok Kyung Kang,&nbsp;Su Bong Nam,&nbsp;Hyun Yul Kim","doi":"10.14216/kjco.21001","DOIUrl":"https://doi.org/10.14216/kjco.21001","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to compare the clinical characteristics and outcomes of hormone receptor-positive (HR+) human epidermal growth factor 2-negative (HER2-) breast cancer among elderly patients (over 65 years old) and younger patients.</p><p><strong>Methods: </strong>This was a retrospective cohort study of 328 patients who were treated for breast cancer at Pusan National University Yangsan Hospital between January 2009 and December 2014. Tumor characteristics, surgical methods, and survival outcomes were compared between the two age groups (<65 and ≥65 years old). Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) were also constructed according to the age groups.</p><p><strong>Results: </strong>Among the 328 patients with HR+ HER2- breast cancer, 184 (56.1%) were <65 years old and 144 (43.9%) were ≥65 years old. Breast cancer stages were similar between the two age groups, but the older patients were treated less often with chemotherapy (81% vs. 66%, P=0.002). During the follow-up period, 17 deaths and 36 cases of recurrence or metastasis were reported. There was no difference in DFS between the two groups (P=0.840); however, the OS of the older age group was significantly lower than that of the younger age group (P=0.015).</p><p><strong>Conclusion: </strong>This study suggested that HR+ HER2- breast cancer patients belonging to the two age groups had no significant difference in DFS. However, older age is an independent factor affecting OS rate. Therefore, even if patients are old, but their physical condition is satisfactory, standard and active treatment may be necessary, similar to that given to younger patients.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/90/kjco-17-1-1.PMC9942741.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival. II期和III期高危结肠癌患者的辅助化疗:阻碍依从性的因素及对长期生存的影响
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21002
Jieun Kim, Ri Na Yoo, Hyeon-Min Cho, Bong-Hyeon Kye, Hyung Jin Kim

Purpose: Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons. This study investigates the hindering factors to the adherence to adjuvant chemotherapy and their impact on long-term survival.

Methods: A retrospective study was conducted for patients with colon cancer and had curative resection from 2009 to 2014. Among patients with pathologic stage II and III, stage II with low-risk features, double primary cancers, R2 resection cases were excluded. Patients were grouped into three groups: no-adjuvant therapy, adjuvant therapy for less than 3 months, and more than 3 months. Factors for withdrawal and the oncologic outcome were analyzed.

Results: Of 571 patients, adjuvant chemotherapy was recommended in 403. One hundred and sixteen patients (28.8%) did not receive adjuvant chemotherapy, 78 (19.4%) withdrew within 3 months, and 209 (51.9%) maintained for more than 3 months. Factors for not receiving adjuvant chemotherapy or withdrawing within 3 months were older than 70 and American Society of Anesthesiologists class 3 or higher. Main reasons for discontinuation before 3 months were chemotoxicity and patient's refusal. The long-term oncologic outcome of the patients who received adjuvant chemotherapy for more than 3 months was significantly better than others.

Conclusion: No-adjuvant therapy or receiving them for lesser than 3 months is significantly affected by the patient's performance status and social support, which coincides with a poor oncologic outcome. Social support and rehabilitation system may help to improve the survival outcome.

目的:结肠癌高危II期和III期患者在根治性手术后推荐辅助化疗。然而,相当一部分患者由于各种原因无法完成预定的辅助治疗。本研究探讨辅助化疗依从性的阻碍因素及其对长期生存的影响。方法:对2009 ~ 2014年行根治性手术的结肠癌患者进行回顾性分析。在病理分期为II期和III期、具有低危特征的II期、双原发癌的患者中,排除R2切除病例。将患者分为无辅助治疗组、辅助治疗时间小于3个月组和辅助治疗时间大于3个月组。分析停药的影响因素及肿瘤预后。结果:571例患者中,403例推荐辅助化疗。116例(28.8%)未接受辅助化疗,78例(19.4%)在3个月内退出,209例(51.9%)维持3个月以上。3个月内未接受辅助化疗或停药的因素为年龄大于70岁且美国麻醉医师学会3级及以上。3个月前停药的主要原因是化学毒性和患者拒绝。接受辅助化疗3个月以上的患者长期肿瘤预后明显优于其他患者。结论:无辅助治疗或接受辅助治疗少于3个月的患者的工作状态和社会支持对其有显著影响,这与不良的肿瘤预后相吻合。社会支持和康复系统可能有助于改善生存结果。
{"title":"Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival.","authors":"Jieun Kim,&nbsp;Ri Na Yoo,&nbsp;Hyeon-Min Cho,&nbsp;Bong-Hyeon Kye,&nbsp;Hyung Jin Kim","doi":"10.14216/kjco.21002","DOIUrl":"https://doi.org/10.14216/kjco.21002","url":null,"abstract":"<p><strong>Purpose: </strong>Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons. This study investigates the hindering factors to the adherence to adjuvant chemotherapy and their impact on long-term survival.</p><p><strong>Methods: </strong>A retrospective study was conducted for patients with colon cancer and had curative resection from 2009 to 2014. Among patients with pathologic stage II and III, stage II with low-risk features, double primary cancers, R2 resection cases were excluded. Patients were grouped into three groups: no-adjuvant therapy, adjuvant therapy for less than 3 months, and more than 3 months. Factors for withdrawal and the oncologic outcome were analyzed.</p><p><strong>Results: </strong>Of 571 patients, adjuvant chemotherapy was recommended in 403. One hundred and sixteen patients (28.8%) did not receive adjuvant chemotherapy, 78 (19.4%) withdrew within 3 months, and 209 (51.9%) maintained for more than 3 months. Factors for not receiving adjuvant chemotherapy or withdrawing within 3 months were older than 70 and American Society of Anesthesiologists class 3 or higher. Main reasons for discontinuation before 3 months were chemotoxicity and patient's refusal. The long-term oncologic outcome of the patients who received adjuvant chemotherapy for more than 3 months was significantly better than others.</p><p><strong>Conclusion: </strong>No-adjuvant therapy or receiving them for lesser than 3 months is significantly affected by the patient's performance status and social support, which coincides with a poor oncologic outcome. Social support and rehabilitation system may help to improve the survival outcome.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"8-14"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/89/kjco-17-1-8.PMC9942742.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erratum to: The current status of cancer survivorship care and a consideration of appropriate care model in Korea. 韩国癌症生存护理的现状和适当护理模式的考虑。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.20024.e1
Hye Mi Ko, Je-Ryong Kim, Jin Sun Lee

[This corrects the article on p. 110 in vol. 16.].

[这是对第16卷第110页的文章的更正]。
{"title":"Erratum to: The current status of cancer survivorship care and a consideration of appropriate care model in Korea.","authors":"Hye Mi Ko,&nbsp;Je-Ryong Kim,&nbsp;Jin Sun Lee","doi":"10.14216/kjco.20024.e1","DOIUrl":"https://doi.org/10.14216/kjco.20024.e1","url":null,"abstract":"<p><p>[This corrects the article on p. 110 in vol. 16.].</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/c9/kjco-17-1-57.PMC9942738.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9210532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor grade 2 as the independent predictor for lymph node metastasis in 10-20 mm sized rectal neuroendocrine tumor. 肿瘤分级2作为10- 20mm大小的直肠神经内分泌肿瘤淋巴结转移的独立预测因子。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21006
Byung-Soo Park, Sung Hwan Cho, Gyung Mo Son, Hyun Sung Kim, Su Jin Kim, Su Bum Park, Cheol Woong Choi, Hyung Wook Kim, Dong Hoon Shin

Purpose: Rectal neuroendocrine tumors (NETs) <10 mm are endoscopically resected, while those ≥20 mm are treated with radical surgical resection. The choice of treatment for 10-20 mm sized rectal NETs remains controversial. This study aimed to verify factors predicting lymph node metastasis (LNM) of 10-20 mm sized rectal NET and utilize them to decide upon the treatment strategy.

Methods: Twenty-eight patients with 10-20 mm sized rectal NETs treated at Pusan National University Yangsan Hospital from January 2009 to September 2020 were divided into LNM (+) and LNM (-) groups, and their respective data were analyzed.

Results: Seven patients (25%) had LNM while 21 patients (75%) did not. Endorectal ultrasound findings showed tumor size was significantly larger in the LNM (+) than in the LNM (-) group (15 mm vs. 10 mm, P=0.018); however, pathologically, there was no significant difference in tumor size (13 mm vs. 11 mm, P=0.109). The mitotic count (P=0.011), Ki-67 index (P=0.008), and proportion of tumor grade 2 patients (5 cases, 71% vs. 1 case, 5%; P=0.001) were significantly higher in the LNM (+) group. In multivariate analysis, tumor grade 2 was the independent factor predicting LNM (odds ratio, 61.32; 95% confidence interval, 3.17-1,188.64; P=0.010).

Conclusion: Tumor grade 2 was the independent factor predicting LNM in 10-20 mm sized rectal NETs. Therefore, it could be considered as the meaningful factor in determining whether radical resection is necessary.

目的:直肠神经内分泌肿瘤(NETs)方法:将2009年1月~ 2020年9月在釜山大学梁山医院治疗的28例10 ~ 20mm直肠神经内分泌肿瘤患者分为LNM(+)组和LNM(-)组,并对各自的数据进行分析。结果:7例(25%)发生LNM, 21例(75%)未发生LNM。直肠内超声检查显示,LNM(+)组肿瘤大小明显大于LNM(-)组(15 mm vs 10 mm, P=0.018);病理上,两组肿瘤大小差异无统计学意义(13 mm vs 11 mm, P=0.109)。有丝分裂计数(P=0.011)、Ki-67指数(P=0.008)、2级肿瘤患者比例(5例,71% vs 1例,5%;P=0.001), LNM(+)组明显增高。在多因素分析中,肿瘤分级2是预测LNM的独立因素(优势比,61.32;95%置信区间为3.17- 1188.64;P = 0.010)。结论:肿瘤分级2是预测10 ~ 20mm直肠网状肿瘤发生LNM的独立因素。因此,它可以被认为是决定是否需要根治性切除的有意义的因素。
{"title":"Tumor grade 2 as the independent predictor for lymph node metastasis in 10-20 mm sized rectal neuroendocrine tumor.","authors":"Byung-Soo Park,&nbsp;Sung Hwan Cho,&nbsp;Gyung Mo Son,&nbsp;Hyun Sung Kim,&nbsp;Su Jin Kim,&nbsp;Su Bum Park,&nbsp;Cheol Woong Choi,&nbsp;Hyung Wook Kim,&nbsp;Dong Hoon Shin","doi":"10.14216/kjco.21006","DOIUrl":"https://doi.org/10.14216/kjco.21006","url":null,"abstract":"<p><strong>Purpose: </strong>Rectal neuroendocrine tumors (NETs) <10 mm are endoscopically resected, while those ≥20 mm are treated with radical surgical resection. The choice of treatment for 10-20 mm sized rectal NETs remains controversial. This study aimed to verify factors predicting lymph node metastasis (LNM) of 10-20 mm sized rectal NET and utilize them to decide upon the treatment strategy.</p><p><strong>Methods: </strong>Twenty-eight patients with 10-20 mm sized rectal NETs treated at Pusan National University Yangsan Hospital from January 2009 to September 2020 were divided into LNM (+) and LNM (-) groups, and their respective data were analyzed.</p><p><strong>Results: </strong>Seven patients (25%) had LNM while 21 patients (75%) did not. Endorectal ultrasound findings showed tumor size was significantly larger in the LNM (+) than in the LNM (-) group (15 mm vs. 10 mm, P=0.018); however, pathologically, there was no significant difference in tumor size (13 mm vs. 11 mm, P=0.109). The mitotic count (P=0.011), Ki-67 index (P=0.008), and proportion of tumor grade 2 patients (5 cases, 71% vs. 1 case, 5%; P=0.001) were significantly higher in the LNM (+) group. In multivariate analysis, tumor grade 2 was the independent factor predicting LNM (odds ratio, 61.32; 95% confidence interval, 3.17-1,188.64; P=0.010).</p><p><strong>Conclusion: </strong>Tumor grade 2 was the independent factor predicting LNM in 10-20 mm sized rectal NETs. Therefore, it could be considered as the meaningful factor in determining whether radical resection is necessary.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"37-43"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/d9/kjco-17-1-37.PMC9942737.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9215082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to: Radiologic intervention due to delayed gastric emptying after pylorus preserving gastrectomy for gastric cancer does not affect pyloric function. 更正:胃癌保幽门胃切除术后胃排空延迟的放射学干预不影响幽门功能。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.20014.e1
Hyun Tae Lim, Shin-Hoo Park, Jong-Ho Choi, Jae Seok Bae, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Se Hyung Kim, Han-Kwang Yang

[This corrects the article on p. 89 in vol. 16.].

[这是对第十六卷第八十九页的文章的更正]。
{"title":"Erratum to: Radiologic intervention due to delayed gastric emptying after pylorus preserving gastrectomy for gastric cancer does not affect pyloric function.","authors":"Hyun Tae Lim,&nbsp;Shin-Hoo Park,&nbsp;Jong-Ho Choi,&nbsp;Jae Seok Bae,&nbsp;Seong-Ho Kong,&nbsp;Do Joong Park,&nbsp;Hyuk-Joon Lee,&nbsp;Se Hyung Kim,&nbsp;Han-Kwang Yang","doi":"10.14216/kjco.20014.e1","DOIUrl":"https://doi.org/10.14216/kjco.20014.e1","url":null,"abstract":"<p><p>[This corrects the article on p. 89 in vol. 16.].</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"56"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/0f/kjco-17-1-56.PMC9942743.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9210531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors related to compliance with adjuvant chemotherapy in patients with gastric cancer: A retrospective single-center study. 胃癌患者辅助化疗依从性的相关因素:一项回顾性单中心研究
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21005
Geon Yi Jin, Ki Bum Park, Kyo Young Song

Purpose: Adjuvant chemotherapy (AC) improves survival outcomes in patients with advanced gastric cancer (GC) after curative surgery; however, some patients do not receive or complete chemotherapy. This study aimed to identify factors related to patient compliance with chemotherapy after curative surgery for advanced GC.

Methods: The data of patients who underwent curative gastrectomy for pathologic stage II-III GC between 2012 and 2016 were reviewed. Patients were divided into an AC completion group (group C), AC incompletion group (group I), and surgery-only group (group S). The AC regimen was either tegafur/gimeracil/oteracil (S-1) or capecitabine plus oxaliplatin (XELOX).

Results: The study enrolled 417 patients; group C had 222 patients, group I had 110, and group S had 85. The most common reason for not initiating AC was poor general condition (36.5%), while chemotherapy-related complications was the common reason for AC incompletion (43.6%). In multivariate analysis, age over 65 years, Eastern Cooperative Oncology Group performance status ≥1, Charlson comorbidity index ≥1, and the presence of postoperative complications were independent risk factors for not initiating AC (odds ratio: 4.32, 2.62, 1.84, and 2.17, respectively). Age over 65 years, longer postoperative stay, and XELOX regimen were significant risk factors for incompletion of AC (odds ratio: 2.68, 1.72, and 2.23, respectively).

Conclusion: Old age, poor performance status, comorbidities, and postoperative complications, longer postoperative hospital stay, and XELOX regimen were associated with poor compliance with AC in GC patients. Clinicians can improve compliance with AC by managing postoperative complications and selecting the most appropriate treatment regimen.

目的:辅助化疗(AC)改善晚期胃癌(GC)术后患者的生存结局;然而,有些患者没有接受或完成化疗。本研究旨在探讨影响晚期胃癌术后患者化疗依从性的因素。方法:回顾性分析2012 - 2016年收治的ⅱ-ⅲ期胃癌根治性胃切除术患者资料。患者分为AC完成组(C组)、AC不完成组(I组)和单纯手术组(S组)。AC方案为替加富/吉美拉西/奥他拉西(S-1)或卡培他滨加奥沙利铂(XELOX)。结果:研究入组417例患者;C组222例,I组110例,S组85例。不启动AC的最常见原因是一般情况不佳(36.5%),而化疗相关并发症是AC不完成的常见原因(43.6%)。在多因素分析中,年龄大于65岁、东部肿瘤合作组工作状态≥1、Charlson合病指数≥1、存在术后并发症是不启动AC的独立危险因素(优势比分别为4.32、2.62、1.84、2.17)。年龄大于65岁、术后时间较长和XELOX方案是AC不完全的重要危险因素(优势比分别为2.68、1.72和2.23)。结论:高龄、运动状态差、合并症、术后并发症、术后住院时间较长、XELOX方案与GC患者AC依从性差相关。临床医生可以通过控制术后并发症和选择最合适的治疗方案来提高AC的依从性。
{"title":"Factors related to compliance with adjuvant chemotherapy in patients with gastric cancer: A retrospective single-center study.","authors":"Geon Yi Jin,&nbsp;Ki Bum Park,&nbsp;Kyo Young Song","doi":"10.14216/kjco.21005","DOIUrl":"https://doi.org/10.14216/kjco.21005","url":null,"abstract":"<p><strong>Purpose: </strong>Adjuvant chemotherapy (AC) improves survival outcomes in patients with advanced gastric cancer (GC) after curative surgery; however, some patients do not receive or complete chemotherapy. This study aimed to identify factors related to patient compliance with chemotherapy after curative surgery for advanced GC.</p><p><strong>Methods: </strong>The data of patients who underwent curative gastrectomy for pathologic stage II-III GC between 2012 and 2016 were reviewed. Patients were divided into an AC completion group (group C), AC incompletion group (group I), and surgery-only group (group S). The AC regimen was either tegafur/gimeracil/oteracil (S-1) or capecitabine plus oxaliplatin (XELOX).</p><p><strong>Results: </strong>The study enrolled 417 patients; group C had 222 patients, group I had 110, and group S had 85. The most common reason for not initiating AC was poor general condition (36.5%), while chemotherapy-related complications was the common reason for AC incompletion (43.6%). In multivariate analysis, age over 65 years, Eastern Cooperative Oncology Group performance status ≥1, Charlson comorbidity index ≥1, and the presence of postoperative complications were independent risk factors for not initiating AC (odds ratio: 4.32, 2.62, 1.84, and 2.17, respectively). Age over 65 years, longer postoperative stay, and XELOX regimen were significant risk factors for incompletion of AC (odds ratio: 2.68, 1.72, and 2.23, respectively).</p><p><strong>Conclusion: </strong>Old age, poor performance status, comorbidities, and postoperative complications, longer postoperative hospital stay, and XELOX regimen were associated with poor compliance with AC in GC patients. Clinicians can improve compliance with AC by managing postoperative complications and selecting the most appropriate treatment regimen.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"31-36"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/4f/kjco-17-1-31.PMC9942746.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9215083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cecal malakoplakia: A case report. 盲肠斑疹1例。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21007
Jin Woon Jeong, Ji Hyun Noh, Jeong Hyun Kang, Ji Hyun Park, Joo Hyung Lee

Malakoplakia is a rare chronic granulomatous disease found in the genitourinary tract, mainly. It is considered to be related to immunosuppression and/or infectious processes. We would like to present an operative case of cecal malakoplakia in a patient with a history of surgical resection and chemotherapy for cervical cancer. A 74-year-old female patient visited our hospital for 1-year follow-up after operation and chemo-radiotherapy for cervical cancer. An infiltrative mass of 6 cm, between the cecal base and the right psoas muscle, was observed on computed tomography. An ileocectomy was performed for diagnosis. Histopathologic examination revealed cecal malakoplakia. After surgery, based on previous reports, antibiotics therapy was added. Then the patient was discharged and treated in the outpatient clinic. To our knowledge, a rare case has been described of cecal malakoplakia during observation after surgery and chemo-radiotherapy for cervical cancer. Malakoplakia is known to be related to immunosuppressive condition. Therefore, our case suggests that close observation should be made in patients on immunosuppressive condition, such as chemotherapy.

Malakoplakia是一种罕见的慢性肉芽肿性疾病,主要发生在泌尿生殖道。它被认为与免疫抑制和/或感染过程有关。我们想提出一个手术病例盲肠斑疹患者的手术切除和化疗的历史为宫颈癌。一名74岁女性患者因宫颈癌手术放疗后到我院随访1年。计算机断层扫描发现盲肠基部与右侧腰肌之间有一个6厘米的浸润性肿块。为诊断,行回肠切除术。组织病理学检查显示盲肠斑疹。手术后,根据先前的报告,添加抗生素治疗。随后患者出院,在门诊接受治疗。据我们所知,在宫颈癌手术和放化疗后的观察中发现了一例罕见的盲肠斑疹。众所周知,斑疹病与免疫抑制有关。因此,我们的病例提示在免疫抑制的情况下,如化疗,应密切观察。
{"title":"Cecal malakoplakia: A case report.","authors":"Jin Woon Jeong,&nbsp;Ji Hyun Noh,&nbsp;Jeong Hyun Kang,&nbsp;Ji Hyun Park,&nbsp;Joo Hyung Lee","doi":"10.14216/kjco.21007","DOIUrl":"https://doi.org/10.14216/kjco.21007","url":null,"abstract":"<p><p>Malakoplakia is a rare chronic granulomatous disease found in the genitourinary tract, mainly. It is considered to be related to immunosuppression and/or infectious processes. We would like to present an operative case of cecal malakoplakia in a patient with a history of surgical resection and chemotherapy for cervical cancer. A 74-year-old female patient visited our hospital for 1-year follow-up after operation and chemo-radiotherapy for cervical cancer. An infiltrative mass of 6 cm, between the cecal base and the right psoas muscle, was observed on computed tomography. An ileocectomy was performed for diagnosis. Histopathologic examination revealed cecal malakoplakia. After surgery, based on previous reports, antibiotics therapy was added. Then the patient was discharged and treated in the outpatient clinic. To our knowledge, a rare case has been described of cecal malakoplakia during observation after surgery and chemo-radiotherapy for cervical cancer. Malakoplakia is known to be related to immunosuppressive condition. Therefore, our case suggests that close observation should be made in patients on immunosuppressive condition, such as chemotherapy.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"44-47"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/d1/kjco-17-1-44.PMC9942739.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extraabdominal parasitic lipoleiomyoma. 腹腔外寄生性脂质肌瘤。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21008
Tae Hoon Lee, Se-Jin Baek

Extrauterine parasitic lipoleiomyoma is a very rare fatty tumor, with uncertain histopathogenesis. Although imaging studies play an important role in preoperative localization and diagnosis of lipoleiomyoma, a pathological evaluation is paramount for confirmation of diagnosis. We describe a case of a 49-year-old woman with a palpable mass in the right inguinal area. Computed tomography of the abdomen and pelvis revealed a fluid- and fat-containing mass. Histopathological examination of the mass, which was successfully resected, confirmed the diagnosis of lipoleiomyoma. The patient was discharged on a postoperative day 2 without any complications.

摘要子宫外寄生性脂肪肌瘤是一种非常罕见的脂肪性肿瘤,其组织发病机制尚不明确。尽管影像学检查在术前定位和诊断脂肪瘤中起着重要的作用,但病理评估对于确诊至关重要。我们描述了一个49岁的妇女与可触及的肿块在右侧腹股沟区。腹部和骨盆的计算机断层扫描显示一个含液体和脂肪的肿块。成功切除的肿块的组织病理学检查证实了脂肪瘤的诊断。患者术后第2天出院,无任何并发症。
{"title":"Extraabdominal parasitic lipoleiomyoma.","authors":"Tae Hoon Lee,&nbsp;Se-Jin Baek","doi":"10.14216/kjco.21008","DOIUrl":"https://doi.org/10.14216/kjco.21008","url":null,"abstract":"<p><p>Extrauterine parasitic lipoleiomyoma is a very rare fatty tumor, with uncertain histopathogenesis. Although imaging studies play an important role in preoperative localization and diagnosis of lipoleiomyoma, a pathological evaluation is paramount for confirmation of diagnosis. We describe a case of a 49-year-old woman with a palpable mass in the right inguinal area. Computed tomography of the abdomen and pelvis revealed a fluid- and fat-containing mass. Histopathological examination of the mass, which was successfully resected, confirmed the diagnosis of lipoleiomyoma. The patient was discharged on a postoperative day 2 without any complications.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"48-51"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/50/kjco-17-1-48.PMC9942745.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An analysis of the outcomes of totally implantable access port implantation performed by surgical residents. 外科住院医师全种植通道植入术的结果分析。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21003
Se-Beom Jeon, Youngbae Jeon, Kyoung-Won Han, Yong-Soon Chun, Jeong-Heum Baek

Purpose: This study aimed to investigate the clinical outcomes after totally implantable access port (TIAP) implantation performed by general surgery residents in patients with colorectal cancer.

Methods: A total of 291 consecutive patients who underwent TIAP implantations were evaluated. The patients were divided into three groups: second-, third-, and fourth-grade residents.

Results: The mean follow-up was 22.1 months (range, 1-87 months). The total times of operation, puncture, and cannulation decreased as the resident grade increased (P<0.001). Early complications significantly decreased with higher resident grades (P=0.039). The non-use of ultrasonography and non-use of C-arm were identified as independent risk factors for complications. Resident grades between second and third (P=0.005) and between second and fourth (P=0.041) were identified as independent risk factors for optimal tip position.

Conclusion: TIAP implantation can be safely and effectively performed by residents. Low-grade residents were associated with early complications.

目的:探讨普外科住院医师在大肠癌患者行TIAP全植入术后的临床效果。方法:对291例连续行TIAP种植的患者进行评估。患者被分为三组:二、三、四年级住院医师。结果:平均随访22.1个月(范围1 ~ 87个月)。手术、穿刺、插管总次数随住院医师等级的增加而减少。结论:住院医师可安全有效地实施TIAP植入术。低度住院患者与早期并发症相关。
{"title":"An analysis of the outcomes of totally implantable access port implantation performed by surgical residents.","authors":"Se-Beom Jeon,&nbsp;Youngbae Jeon,&nbsp;Kyoung-Won Han,&nbsp;Yong-Soon Chun,&nbsp;Jeong-Heum Baek","doi":"10.14216/kjco.21003","DOIUrl":"https://doi.org/10.14216/kjco.21003","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the clinical outcomes after totally implantable access port (TIAP) implantation performed by general surgery residents in patients with colorectal cancer.</p><p><strong>Methods: </strong>A total of 291 consecutive patients who underwent TIAP implantations were evaluated. The patients were divided into three groups: second-, third-, and fourth-grade residents.</p><p><strong>Results: </strong>The mean follow-up was 22.1 months (range, 1-87 months). The total times of operation, puncture, and cannulation decreased as the resident grade increased (P<0.001). Early complications significantly decreased with higher resident grades (P=0.039). The non-use of ultrasonography and non-use of C-arm were identified as independent risk factors for complications. Resident grades between second and third (P=0.005) and between second and fourth (P=0.041) were identified as independent risk factors for optimal tip position.</p><p><strong>Conclusion: </strong>TIAP implantation can be safely and effectively performed by residents. Low-grade residents were associated with early complications.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"17 1","pages":"15-22"},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/38/ba/kjco-17-1-15.PMC9942736.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Korean journal of clinical oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1